KP
ZBH icon

Kiltearn Partners’s Zimmer Biomet ZBH Stock Holding History

Kiltearn Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-229,793
Closed -$26.6M – 29
2020
Q2 		$26.6M Sell
229,793
-255,749
-53% -$29.5M 1.51% 25
2020
Q1 		$47.6M Sell
485,542
-13,390
-3% -$1.76M 3.17% 15
2019
Q4 		$72.5M Sell
498,932
-54,590
-10% -$7.54M 2.74% 19
2019
Q3 		$72.1M Sell
553,522
-42,436
-7% -$5.48M 2.62% 22
2019
Q2 		$68.1M Sell
595,958
-55,826
-9% -$6.54M 2.16% 23
2019
Q1 		$80.8M Sell
651,784
-168,817
-21% -$19.2M 2.3% 21
2018
Q4 		$82.6M Buy
820,601
+101,043
+14% +$11.4M 2.32% 24
2018
Q3 		$91.8M Buy
719,558
+71,695
+11% +$8.52M 2.12% 25
2018
Q2 		$70.1M Buy
+647,863
New +$70.5M 1.58% 27

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Kiltearn Partners's ZBH Position: Q3 2020 in Review

Kiltearn Partners sold out of Zimmer Biomet (ZBH) in Q3 2020, closing a stake of 229,793 shares — an estimated $26.6M sold.

Kiltearn Partners first reported a position in ZBH in Q2 2018 and held it in 9 quarters. The position peaked at $91.8M in Q3 2018. 930 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

  • Kiltearn Partners reported no remaining Zimmer Biomet position as of Q3 2020 after selling out during the quarter.
  • Kiltearn Partners sold 229,793 Zimmer Biomet shares in Q3 2020, an estimated $26.6M.
  • Kiltearn Partners first reported a position in Zimmer Biomet in Q2 2018 and held it in 9 quarters.
  • Kiltearn Partners's Zimmer Biomet position peaked at $91.8M in Q3 2018.
  • 930 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on Kiltearn Partners's 13F filing for Q3 2020, filed 16 Nov 2020.